February 9, 2018 07:32 AM EST

Seattle Genetics seeds a new immuno-oncology collaboration with the protein explorers at Pieris

Seattle Genetics $SGEN believes it could achieve some blockbuster cancer drug work by teaming up with the protein engineers at Pieris $PIRS.

The Seattle-based biotech …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Seat­tle Ge­net­ics seeds a new im­muno-on­col­o­gy col­lab­o­ra­tion with the pro­tein ex­plor­ers at Pieris